A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency

RecruitingOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

September 6, 2024

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Protein C Deficiency
Interventions
DRUG

Freeze-dried Human Protein C Concentrate

Freeze-dried Human Protein C Concentrate (TAK-662) intravenous injection

Trial Locations (1)

Unknown

RECRUITING

Takeda selected site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY